Companies / EMBC Embecta Corp. (EMBC)
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Ticker EMBC Exchange Nasdaq Sector Healthcare Industry Medical Instruments & Supplies Market cap $350.72M 52-week range $2.77 - $14.91 Valuation Share price $6.19 (close of Nov 6, 2026) P/E (TTM) 4.13x Price to book -0.57x Price to free cash flow 2.13x Enterprise value $1.62B Book value per share $-10.81 Price performance Period Change 1 day -2.21% 5 days -0.96% 1 month +4.03% 3 months +76.86% 6 months +73.88% Year to date -47.90% 1 year -54.01% 3 years -60.52% All time -86.83%
Short interest As of Oct 15, 2026 Short % of float 12.46% Shares short 5.87M Days to cover 6.16 Change since prior report +0.76% Source FINRA consolidated short interest Profitability and growth Return on invested capital 25.80% Return on assets 8.75% Return on capital employed 29.19% Gross margin 62.64% Net margin 8.83% EBITDA margin 26.18% Revenue growth -3.80% Net income growth 21.84% Cash flow and balance sheet Free cash flow yield (TTM) 46.93% Current ratio 1.68x Net debt to EBITDA 4.78x Latest reported year Period end Sep 30, 2025 Fiscal year 2025 Revenue $1.08B Cost of revenue $403.60M Gross profit $676.80M EBITDA $282.80M Net income $95.40M Earnings per share $1.64 Research and development $37.30M Interest expense $107.30M Shares outstanding 58.31M Income statement by year Period end Revenue Gross profit Net income EPS 2025-09-30 $1.08B $676.80M $95.40M $1.64 2024-09-30 $1.12B $735.20M $78.30M $1.36 2023-09-30 $1.12B $749.90M $70.40M $1.23 2022-09-30 $1.13B $774.90M $223.60M $3.92 2021-09-30 $1.17B $800.40M $414.80M $7.28 2020-09-30 $1.09B $762.60M $427.60M $7.50 2019-09-30 $1.11B $786.00M $432.00M $7.58
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-09-30 62.64% 8.83% - 25.80% 2024-09-30 65.46% 6.97% - 19.17% 2023-09-30 66.91% 6.28% - 22.80% 2022-09-30 68.61% 19.80% - 36.76% 2021-09-30 68.69% 35.60% 69.80% 68.83% 2020-09-30 70.25% 39.39% 74.76% 74.23% 2019-09-30 70.87% 38.95% 74.87% 75.22%
Cash and debt by year Period end Cash Debt 2025-09-30 $225.50M $1.39B 2024-09-30 $267.50M $1.57B 2023-09-30 $326.30M $1.59B 2022-09-30 $330.90M $1.60B
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-09-30 $182.40M $31.60M 2024-09-30 $19.90M $26.30M 2023-09-30 $41.20M $21.50M 2022-09-30 $388.60M $18.70M 2021-09-30 $419.50M $12.80M 2020-09-30 $456.60M $12.70M 2019-09-30 $436.00M $12.00M
Dividend history Most recent payment Aug 27, 2026 Paid in the last twelve months $0.32 Payment date Dividend per share 2026-08-27 $0.01 2026-05-28 $0.01 2026-02-27 $0.15 2025-12-05 $0.15 2025-08-29 $0.15 2025-05-28 $0.15 2025-02-28 $0.15 2024-12-06 $0.15
Investor relations Next earnings report Next confirmed report Nov 24, 2026 Consensus EPS estimate $0.31 Past earnings dates Reported Fiscal period EPS estimate 2026-08-07 Jun 2026 $0.26 2026-05-05 Mar 2026 $0.42 2026-02-05 Dec 2025 $0.67 2025-11-25 Sep 2025 - 2025-08-08 Jun 2025 - 2025-05-09 Mar 2025 $0.66 2025-02-06 Dec 2024 $0.45 2024-11-26 Sep 2024 $0.40
Filings and sources Company website embecta.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports Similar companies Intuitive Surgical Inc (ISRG) · Becton Dickinson & Co (BDX) · Medline Inc. (MDLN) · ResMed Inc (RMD) · Alcon Inc (ALC) · West Pharmaceutical Services Inc (WST) · Solventum Corp (SOLV) · Baxter International Inc (BAX)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades